Eficacia de la estrategia de control del ritmo en pacientes con miocardiopatía hipertrófica y fibrilación o flutter auricular sometidos a cardioversión eléctrica
DOI:
https://doi.org/10.29166/ciencias_medicas.v42i1.1510Keywords:
hypertrophic cardiomyopathy, Atrial fibrillation, Atrial flutter, ElectricalAbstract
Background: fibrillation and atrial flutter are frequent arrhythmias in patients with hypertrophic cardiomyopathy and increase their morbidity. Cardioversion of arrhythmia improves the quality of life of the patient; however, there is no information on the efficacy or predictors of this therapy in the literature.
Aim: to identify the variables related to the evolution of the arrhythmia after therapy in patients with hypertrophic cardiomyopathy associated with atrial fibrillation or flutter were underwent electrical cardioversion.
Methods: data from 37 patients with atrophic cardiomyopathy associated with atrial fibrillation (n = 21) and atrial flutter (n = 16), submitted to electrical cardioversion, were analyzed for immediate success (reversion after shock), Recurrence (recurrence of the problem after electrical cardioversion) and late success (sinus rhythm observed at the last recorded visit).
Results: immediate success occurred in 96% of electrical cardioversion procedures in patients with atrial fibrillation and in 100% of patients with atrial flutter. Recurrence occurred in 76.9% of patients with atrial fibrillation who underwent electrical cardioversion after an average time of 630 days and in 57.1% of patients with atrial flutter after a follow-up of 1,138 days.
Conclusion: the efficacy of electrical cardioversion was evaluated, by the clinical results observed in patients with hypertrophic cardiomyopathy associated with atrial fibrillation or flutter; in addition, variables related to recurrence and late success after electrical cardioversion, were identified.
Downloads
Metrics
References
Gersh BJ, Maron BJ, Bonow RO, et al. 2011 ACC/AHA Guideline for the diagnosis and treatment of hypertrophic cardiomyopathy. A report of the American College of Cardiology and American Heart Association Task Force on practice Guidelines. Circulation 2011; 124:783-831.
Elliot PM, Anastasakis A, Borger MA, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. Eur Heart J (2014) doi: 10,1093/eurheartj/ehu284 First published online:August 29, 2014.
Guttman OP, Rahman MS, O’Mahony C, et al. Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review. Heart 2014; 100:465-472.
Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the queclinical course of hypertrophic cardiomyopathy. Circulation, 2011; 104:2517-2524.
Maron BJ, Olivotto I, Bellone P, et al. Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002; 39:301-307.
Camm AJ, Kirchhof P, Lip GY, et al. 2012 focused update of the ESC guidelines for the management of atrial fibrillation. Develop with the especial contribution of European Heart Rhythm Association. Eur Heart J 2012; 33:2719-2747.
Robinson K, Frenneaux MP, Stockins B, Karatasakis G, Poloniecki JD, McKenna WJ. Atrial fibrillation in hypertrophic cardiomyopathy: a longitudinal study. J Am Coll Cardiol 1990; 1515:1279-1285.
Boriani G, Diemberger I, Biffi M, et al. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of lon g-term outcome. Int J Clin Pract 2007; 61(5):748-56.
Derejko P, Polańska M, Chojnowska L, et al. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate. Kardiologia Polska 2013;71(1):17–24
Volgman AS, Soble JS, Neumann A, et al. Effect of left atrial size on recurrence of atrial fibrillation after electrical cardioversion: atrial dimension versus volume. Am J Card Imaging 1996; 10(4):261-5.
Kumar P, Patel A, Mounsey JP, et al. Effect of left ventricular diastolic dysfunction on outcomes of atrial fibrillation ablation. Am J Cardiol 2014; 114(3):407-11.
Melduni R, Malouf J, Chandrasekaran K, et al. New insights into the predictors of left atrial stunning after successful direct-current cardioversion of atrial fibrillation and flutter. J Am Soc Echocardiogr 2008;21(7):848-54.
Maounis T, Kyrozi E, Katsaros K, et al. The prognostic significance of atrial arrhythmias recorded early after cardioversion for atrial fibrillation. Pacing Clin Electrophysiol 2001; 24(7):1076-81.
Arriagada G, Berruezo A, Mont L, et al. Predictors of arrhythmia recurrence in patients with lone atrial fibrillation. Europace 2008; 10:9–14.
